Skip to content

Culturally Adapted i-CBT for Farsi/Dari Speaking Migrants

Culturally and Language-Adapted i-CBT for Common Mental Health Problems: A Randomized Controlled Study With Farsi/Dari-Speaking Migrants

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06828276
Acronym
i-CBT
Enrollment
128
Registered
2025-02-14
Start date
2025-03-25
Completion date
2026-12-31
Last updated
2025-12-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety Symptoms, Common Mental Health Problems, Depressive Symptoms, Grief, Insomnia, Marital Relationship, Psychological Trauma, Psychological Well Being, Resilience, Rumination, Stress, Wellbeing

Keywords

Refugee, Cognitive behavioral therapy, Psychological problems, Persian speaking, Psychological well-being, Youth, Mental problems, Resilience, Asylum seeker

Brief summary

The aim of this randomized controlled trial (RCT) is to investigate the effectiveness of a culturally adapted internet-based cognitive behavioral therapy (i-CBT) intervention in reducing symptoms of common mental health issues among Farsi/Dari-speaking youth migrants and refugees. Investigator hypothesizes that there will be a significant decrease in psychological symptoms after participants receive the intervention compared to a control group.

Detailed description

Participants who are included in the study will be allocated to the experimental group and the control group (waiting list). Participants will be invited to participate tailored i-CBT intervention over 10-weeks. Intervention covers common psychological issues. Participants will have access to support through a chatting function, during the interventional period. Intervention effects will be measured prior-treatment, post-treatment, and 6 months post-treatment.

Interventions

BEHAVIORALCulturally adapted i-CBT

A culturally and language adapted i-CBT intervention for Farsi/Dari speaking youth migrants and refugees. The intervention targets mild to moderate common mental health problems.

Sponsors

Linkoeping University
CollaboratorOTHER_GOV
Karolinska Institutet
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Masking description

No masking

Eligibility

Sex/Gender
ALL
Age
15 Years to 29 Years
Healthy volunteers
No

Inclusion criteria

* Between the ages of 15 and 29. * A score above the cut-off 1.75 on HSCL-25 * Has a refugee or migrant background * Has a good and stable internet connection * Has access to a computer, tablet or smartphone * Is fluent in reading and writing Arabic * Has the ability to dedicate time to take part in the intervention for 6-10 weeks.

Exclusion criteria

* Is suffering from a severe mental illness, such as psychosis or severe depression. * Is suffering from substance abuse * Is undergoing a psychological treatment * Has a high risk of suicide

Design outcomes

Primary

MeasureTime frameDescription
Hopkins Symptom Checklist-25 (HSCL-25)Pre-intervention, up to 5 weeks, immediately after the intervention, 6 months after completion of the interventionAssessment of anxiety and depressive symptoms. HSCL-25 consists of 25 items.Each item is rated on a scale from 1 to 4, where 1 means Not at all and 4 means Extremely.Higher scores indicate a worse outcome, as they reflect greater severity of symptoms.

Secondary

MeasureTime frameDescription
Insomnia Severity Index (ISI)Pre-intervention, immediately after the intervention, 6 months after completion of the interventionAssessment of severity of insomnia symptoms. ISI consists of 7 items, each rated on a scale from 0 to 4.Higher scores indicate a worse outcome, as they reflect more severe insomnia symptoms.
Prolonged Grief Disorder (PG-13)Pre-intervention, immediately after the intervention, 6 months after completion of the interventionAssessment of prolonged grief disorder. The PG-13 consists of 13 items, each rated on a scale from 1 to 5, where 1 means Not at all and 5 means Several times a day. Higher scores indicate a worse outcome, as they reflect more severe symptoms of prolonged grief.
Posttraumatic Stress Disorder Checklist (PCL-5)Pre-intervention, immediately after the intervention, 6 months after completion of the interventionAssessment of symptoms of post-traumatic stress disorder. The PCL-5 consists of 20 items, each rated on a scale from 0 to 4. The total score ranges from 0 to 80. Higher scores indicate a worse outcome, as they reflect greater severity of PTSD symptoms.
Psychological Outcome Profiles (PSYCHLOPS)Pre-intervention, immediately after the intervention, 6 months after completion of the interventionImpact of problematic area on function. PSYCHLOPS questionnaire consists of 4 items. These items are designed to capture the patient's main problem, the impact of this problem on their daily life, and their overall well-being. Each question in PSYCHLOPS is scored on a scale from 0 to 5, where 0 indicates no problem and 5 indicates the most severe problem. Higher scores indicate a worse outcome, as they reflect greater severity of problems or distress.
Brief Resilience Scale (BRS)Pre-intervention, immediately after the intervention, 6 months after completion of the interventionAssessment of resilience.The BRS consists of 6 items, each rated on a scale from 1 to 5. Higher scores indicate a better outcome, as they reflect greater resilience.
Client Satisfaction Questionnaire (CSQ-3)Immediately after the intervention, 6 months after completion of the interventionAssessment of the levels of satisfaction of the participant with the intervention.CSQ-3 consists of 3 items. Each item is rated on a scale from 1 to 4. Higher scores indicate a better outcome, as they reflect greater satisfaction with the services received.
The World Health Organization-Five Well-Being Index (WHO-5)Pre-intervention, immediately after the intervention, 6 months after completion of the interventionAssessment of subjective psychological well-being.The WHO-5 consists of 5 items, each rated on a scale from 0 to 5. Higher scores indicate a better outcome, as they reflect higher levels of well-being.

Countries

Sweden

Contacts

Primary ContactShervin Shahnavaz, PhD
shervin.shahnavaz@ki.se0046722154769
Backup ContactAnahita Geranmayeh, MSc
Anahita.geranmayeh@ki.se0046737121661

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026